HCA Healthcare (NYSE:HCA – Get Free Report) had its price target lowered by equities research analysts at KeyCorp from $475.00 to $435.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. KeyCorp’s target price points to a potential upside of 13.79% from the stock’s previous close.
Other analysts also recently issued research reports about the company. Argus cut their price target on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a report on Monday, May 4th. Stephens cut their price target on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. Wells Fargo & Company set a $369.00 price target on HCA Healthcare in a report on Monday, July 20th. Barclays cut their target price on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating for the company in a research report on Monday. Finally, Wall Street Zen cut shares of HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Fourteen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $478.73.
Read Our Latest Analysis on HCA Healthcare
HCA Healthcare Stock Performance
HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping the consensus estimate of $7.56 by $0.03. The firm had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. HCA Healthcare’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.84 earnings per share. As a group, sell-side analysts predict that HCA Healthcare will post 29.19 earnings per share for the current year.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the stock. Sumitomo Life Insurance Co. lifted its holdings in shares of HCA Healthcare by 1.0% during the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock worth $946,000 after acquiring an additional 20 shares during the period. MJP Associates Inc. ADV increased its holdings in HCA Healthcare by 2.9% during the 4th quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock valued at $350,000 after purchasing an additional 21 shares in the last quarter. Cary Street Partners Investment Advisory LLC boosted its stake in HCA Healthcare by 7.5% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock worth $140,000 after purchasing an additional 21 shares in the last quarter. Anchyra Partners LLC increased its stake in shares of HCA Healthcare by 3.7% in the first quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock valued at $278,000 after buying an additional 21 shares in the last quarter. Finally, Plato Investment Management Ltd lifted its position in HCA Healthcare by 0.6% during the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock worth $1,833,000 after buying an additional 22 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.
About HCA Healthcare
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Recommended Stories
- Five stocks we like better than HCA Healthcare
- Meta Earnings Put AI Spending and Ad Growth Back in Focus
- These 3 AI Winners Don’t Sell the Tech—They Use It
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
